|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/20 | (2006.01) |
| A61K 31/55 | (2013.01) | ||
| A61K 31/55 | (2006.01) | ||
| A61K 31/20 | (2013.01) | ||
| A61P 13/12 | (2006.01) | ||
| A61P 13/12 | (2018.01) |
| (11) | Number of the document | 4346795 |
| (13) | Kind of document | T |
| (96) | European patent application number | 22740572.7 |
| Date of filing the European patent application | 2022-06-01 | |
| (97) | Date of publication of the European application | 2024-04-10 |
| (45) | Date of publication and mention of the grant of the patent | 2025-03-05 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2022/031729 |
| Date | 2022-06-01 |
| (87) | Number | WO 2022/256378 |
| Date | 2022-12-08 |
| (30) | Number | Date | Country code |
| 202163195843 P | 2021-06-02 | US | |
| 202163275077 P | 2021-11-03 | US |
| (72) |
PASTOR-SOLER, Nuria M. , US
HALLOWS, Kenneth R. , US
PINKOSKY, Stephen L. , US
SASIELA, William J. , US
HALL, Ashley F. , US
|
| (73) |
Esperion Therapeutics, Inc. ,
3891 Ranchero Drive
Suite 150, Ann Arbor, MI 48108,
US
|
| (54) | COMPOSITIONS CONTAINING BEMPEDOIC ACID ALONE OR IN COMBINATION WITH TOLVAPTAN FOR USE IN A METHOD FOR TREATING AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD) |
| COMPOSITIONS CONTAINING BEMPEDOIC ACID ALONE OR IN COMBINATION WITH TOLVAPTAN FOR USE IN A METHOD FOR TREATING AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD) |